SENSEX    72488.99       -454.69    |    NIFTY    21995.85       -152.05 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Tata Steel, Sun Pharma to react to Q2 results
14-Nov-18   08:47 Hrs IST

Tata Steel's consolidated net profit jumped 206.18% to Rs 3116.20 crore on 34.82% rise in total income to Rs 44175.53 crore in Q2 September 2018 over Q2 September 2017. The result was announced after market hours yesterday, 13 November 2018.

Sun Pharmaceuticals Industries reported consolidated net loss of Rs 108.84 crore in Q2 September 2018 as compared to net profit of Rs 1001.79 crore in Q2 September 2017. Total income rose 5.56% to Rs 7288.78 crore in Q2 September 2018 over Q2 September 2017. The result was announced after market hours yesterday, 13 November 2018.

Glenmark Pharmaceuticals' consolidated net profit advanced 93.35% to Rs 414 crore on 26.33% rise in total income to Rs 2888.39 crore in Q2 September 2018 over Q2 September 2017. The result was announced after market hours yesterday, 13 November 2018.

Ashok Leyland's net profit surged 37.49% to Rs 459.58 crore on 24.53% rise in total income to Rs 7636.13 crore in Q2 September 2018 over Q2 September 2017. The result was announced after market hours yesterday, 13 November 2018.

Sasken Technologies said that as a matter of abundant caution, the company has received an assessment order under Section 143(3) of the Income Tax Act, 1961 for the Assessment Year 2016-17 wherein a sum of about Rs 68 crore including interest was raised as tax demand on the company. However, the company stand by the position taken in the Income Tax Return filed for the year and is in the process of filing an appeal against the order. The announcement was made after market hours yesterday, 13 November 2018.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.85 88.79 1.06
United Kingdom (GBP) 1.17 1.00 103.96 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.80 83.59 1.00
Market News << ALL News
  18-Apr-2024, (05:49 )  Infosys Q4 PAT climb..
  18-Apr-2024, (05:25 )  Bajaj Auto Q4 PAT cl..
  18-Apr-2024, (03:39 )  HDFC Life gains afte..
  18-Apr-2024, (03:00 )  Sterlite Technologie..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)